Terms: = Gastric cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393 AND Treatment
1 results:
1. Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer.
Luo HY; Wang ZQ; Wang FH; Qiu MZ; Teng KY; Ruan DY; He YJ; Li YH; Xu RH
Am J Clin Oncol; 2011 Dec; 34(6):555-60. PubMed ID: 22101386
[TBL] [Abstract] [Full Text] [Related]
